These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25139714)

  • 21. Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3 may serve as novel biomarkers for colorectal cancer.
    Wang L; Zhao Y; Xu M; Zhou F; Yan J
    J BUON; 2019; 24(3):1120-1127. PubMed ID: 31424670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B7-H3 is spliced by SRSF3 in colorectal cancer.
    Zhang C; Chen Y; Li F; Yang M; Meng F; Zhang Y; Chen W; Wang W
    Cancer Immunol Immunother; 2021 Feb; 70(2):311-321. PubMed ID: 32719950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN.
    Luo D; Xiao H; Dong J; Li Y; Feng G; Cui M; Fan S
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1246-1251. PubMed ID: 27939887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
    Su TC; Chen CY; Tsai WC; Hsu HT; Yen HH; Sung WW; Chen CJ
    PLoS One; 2018; 13(10):e0204866. PubMed ID: 30286126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10.
    Liu C; Liu J; Wang J; Liu Y; Zhang F; Lin W; Gao A; Sun M; Wang Y; Sun Y
    Mol Med Rep; 2013 Jan; 7(1):134-8. PubMed ID: 23128494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and Clinical Significance of Immune Checkpoint Regulator B7-H3 (CD276) in Human Meningioma.
    Deng J; Ma M; Wang D; Zhu H; Hua L; Sun S; Chen H; Cheng H; Qian ZR; Xie Q; Zhang T; Gong Y
    World Neurosurg; 2020 Mar; 135():e12-e18. PubMed ID: 31629137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu.
    Sun ZZ; Zhang T; Ning K; Zhu R; Liu F; Tang SC; Jiang B; Hua D
    Oncol Rep; 2016 Jul; 36(1):231-8. PubMed ID: 27175567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention.
    Varghese E; Samuel SM; Brockmueller A; Shakibaei M; Kubatka P; Büsselberg D
    Cancer Metastasis Rev; 2024 Mar; 43(1):115-133. PubMed ID: 37768439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
    Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
    Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma.
    Zhao J; Meng Z; Xie C; Yang C; Liu Z; Wu S; Wang B; Fan P; Jin X; Wu H
    Int J Biochem Cell Biol; 2019 Mar; 108():84-91. PubMed ID: 30664982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
    Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
    Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival.
    Koyama Y; Morikawa T; Miyama Y; Miyakawa J; Kawai T; Kume H; Sawabe M; Ushiku T
    Pathol Res Pract; 2020 Dec; 216(12):153219. PubMed ID: 33049447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.
    Wang J; Chong KK; Nakamura Y; Nguyen L; Huang SK; Kuo C; Zhang W; Yu H; Morton DL; Hoon DS
    J Invest Dermatol; 2013 Aug; 133(8):2050-8. PubMed ID: 23474948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis.
    Benzon B; Zhao SG; Haffner MC; Takhar M; Erho N; Yousefi K; Hurley P; Bishop JL; Tosoian J; Ghabili K; Alshalalfa M; Glavaris S; Simons BW; Tran P; Davicioni E; Karnes RJ; Boudadi K; Antonarakis ES; Schaeffer EM; Drake CG; Feng F; Ross AE
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):28-35. PubMed ID: 27801901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients.
    Pizon M; Schott DS; Pachmann U; Pachmann K
    Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma.
    Wang Y; Deng J; Wang L; Zhou T; Yang J; Tian Z; Yang J; Chen H; Tang X; Zhao S; Zhou L; Tong A; Xu J
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.
    Nygren MK; Tekle C; Ingebrigtsen VA; Mäkelä R; Krohn M; Aure MR; Nunes-Xavier CE; Perälä M; Tramm T; Alsner J; Overgaard J; Nesland JM; Borgen E; Børresen-Dale AL; Fodstad Ø; Sahlberg KK; Leivonen SK
    Br J Cancer; 2014 Apr; 110(8):2072-80. PubMed ID: 24577056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3.
    Wang S; Mou J; Cui L; Wang X; Zhang Z
    Biomed Pharmacother; 2018 Jun; 102():1037-1044. PubMed ID: 29710520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population?
    Liu Y; Vlatkovic L; Sæter T; Servoll E; Waaler G; Nesland JM; Giercksky KE; Axcrona K
    Int J Urol; 2012 Aug; 19(8):749-56. PubMed ID: 22487487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion.
    Huang L
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6759-6766. PubMed ID: 32633367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.